Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
暂无分享,去创建一个
L. Bubendorf | R. Stahel | S. Peters | T. Stinchcombe | M. Tiseo | P. Garrido | C. Baik | Michael W. Lu | P. Bonomi | D. Isla | D. Kowalski | A. Villegas | A. Rittmeyer | C. Meyenberg | J. C. Carpeño | L. H. Lam | S. de Haas | Christoph Meyenberg